MSH6 and medulloblastoma: Because six of the ten previously published CMMRD cases with medulloblastoma were also MSH6-deficient, and given that only approximately 20% of CMMRD patients are due to biallelic MSH6 mutations, this suggests an over-representation of medulloblastoma among MSH6-deficient individuals.